slides · global inventory
List
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,471
Current window 38,791-38,820
Pages 3,683
Rows per page 30
Component
38,791-38,820 of 110,471
31
The chart is a box plot showing variance reduction in forecasting as the number of sites increases.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
32
The slide uses a split-chart approach to show historical annual growth alongside recent semi-annual growth.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
33
The slide uses a split-view comparing historical annual data with recent half-year (1H) performance.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
34
Allego | Investor Presentation Deck | 50 slidesAllego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
34
Allego | Investor Presentation Deck | 50 slidesAllego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
43
The slide uses a split-layout to contrast a specific deep-dive (Amsterdam) with a broader overview of fleet partnerships.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
43
The slide uses a split-layout to contrast a specific deep-dive (Amsterdam) with a broader overview of fleet partnerships.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
47
The slide provides a profile of a strategic partner/investor.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
47
The slide acts as a partner profile/due diligence summary for a key stakeholder.Allego | Investor Presentation Deck | 50 slides · Allego
Pitch deck Investor relations 2 hits
08
Allscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slidesAllscripts Healthcare Solutions | Investor Day Presentation Deck | 57 slides · Veradigm
Conference presentation Investor relations Beat · WhyLoop · Golden Circle2 hits
09
The slide highlights a flawed sale process and negative shareholder/analyst sentiment.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Problem2 hits
28
Uses a line chart to show historical valuation trends and a bar chart to compare valuation compression across peers.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution2 hits
29
Uses a stock price chart to anchor the argument that the company was trading at a level where a standard premium would have exceeded $100/share.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution2 hits
36
Includes three news clippings as evidence of recent deal activity.Altair US LLC | Activist Presentation Deck | 38 slides · Altair US, LLC
Activist deck Activist investor Beat · Solution2 hits
03
Includes logos for AMMO, STELTH, STREAK, and GunBroker.com.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations Beat · Problem2 hits
08
Includes FY 2022 actuals and FY 2023 estimates for Net Revenue and Adj. EBITDA.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 2 hits
11
Includes two bar charts showing historical and estimated revenue and EBITDA.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 2 hits
18
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 2 hits
09
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)2 hits
15
The slide uses a process flow diagram to illustrate the progression from Part A to Part B.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
16
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
24
The chart displays a time-course study of VAS (Visual Analog Scale) scores for 'feeling high' across three cohorts.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Jobs To Be Done2 hits
46
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
47
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
10
The slide uses a diagram of an antibody to map specific functional regions to their biological mechanisms.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle2 hits
12
The slide uses a simple additive framework to show how immune response and clinical activity lead to a strategic positioning as a 'backbone' therapy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction2 hits
16
The slide uses a before-and-after medical imaging comparison to validate clinical efficacy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction2 hits
20
The slide uses a two-part structure: a value proposition box followed by a list of upcoming milestones.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction2 hits
03
Comparison of Tmax metrics and safety profiles for single vs repeat dosing.Aquestive Therapeutics | Results Presentation Deck | 14 slides · Aquestive Therapeutics
Deck Investor relations Beat · Solution (Provide relief)2 hits
08
The slide uses a two-column layout to contrast the drug's engineering/profile with its biomarker/IP strategy.Aravive | Investor Presentation Deck | 39 slides · Aravive
Pitch deck Investor relations Beat · Agitate (Make it worse)2 hits